monoclonalantibodies

  • Experimental Alzheimer’s Drug Succeeds in Large Trial, but Questions Remain

    Experimental Alzheimer’s Drug Succeeds in Large Trial, but Questions Remain

    An experimental drug for Alzheimer’s disease appears to have shown successful results in a major large-scale clinical trial. The drug’s makers announced Tuesday that their treatment slowed down people’s rate of cognitive decline in a Phase III trial. The findings will likely pave the way for the drug’s approval in the U.S. and elsewhere, but…